Alzheimer Disease Research Center (ADRC) Developmental Projects
This UCSF grant funds early career researchers for innovative two-year projects on Alzheimer’s disease, focusing on disease heterogeneity and underrepresented populations using diverse scientific approaches.
Funder: University of California San Francisco
Due Dates (Anticipated): October 2026 (Fall cycle full application deadline, projected)
Funding Amounts: $75,000/year for 2 years (total $150,000 direct costs) per project; up to 2 projects funded annually
Summary: Funds early career investigators for innovative two-year research on Alzheimer’s disease and related dementias, emphasizing heterogeneity and underrepresented populations.
Key Information: Fall cycle only; not renewable; targeted to postdocs, fellows, instructors, and assistant professors.
Description
The Alzheimer Disease Research Center (ADRC) Developmental Projects grant supports up to two innovative research projects per year, each funded for two years, with a focus on Alzheimer’s disease and related disorders (ADRD). The program is designed to advance biomedical research, spanning basic science, clinical/translational studies, health policy, social science, and population science. It is especially geared toward early career investigators, providing resources to establish new lines of inquiry—such as pilot studies or initial data collection—with the goal of positioning recipients for future NIH-level funding.
Projects should align with the ADRC’s central theme of heterogeneity in dementia, with a special emphasis on atypical or young-onset presentations and underrepresented populations (including Chinese Americans, Latino Americans, and Black/African Americans). The ADRC encourages studies leveraging clinical, pathological, biomarker, and imaging data to explore the clinical, genetic, pathological, and molecular aspects of Alzheimer’s and related neurodegenerative diseases.
Clinical trials and studies by associate professors or those not relevant to neurodegenerative disease are not eligible. The award is not renewable and requires progress reporting.
